Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Turkey

Sandoz Re-enters Turkish Market

March 2006 | Company Finance Alert

Generics maker Sandoz, a division of Swiss drugmaker Novartis, has re-entered the Turkish market after an absence of more than a decade. When Novartis acquired German generics firm Hexal, the Ilsan Hexal division in Turkey joined the Sandoz stable. Sandoz-Turkey will operate in three factories in Gebze, Pendik and Tuzla under the name Sandoz Ilac.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Middle East & Africa Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Middle East & Africa Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Eczacibasi Considers Divestment

Companies / Turkey Turkish industrial group Eczacibasi is reported to be considering divesting a 50% stake in its generic drug unit. According to industry sources, the whole division is valued at around US$650mn. In...
December 2006
Drug Sector Benefits From Rising FDI

Companies / Turkey The Turkish Confederation of Employer Associations (TISK) has stated that in 2005 Turkey was the leading Mediterranean country in terms of Foreign Direct Investment (FDI). The confederation claimed that...
November 2006
Sanovel Ilac Opens New Plant

Companies / Turkey Turkish drugmaker Sanovel Ilac will open its new TRY192mn (US$144.85mn) production facility shortly. Construction on the 120,000 m2 plant began in 2001and when fully operational it will have an annual...
April 2006
Turkish Drug Sales Soar, Eczacibasi Expands

Companies / Turkey According to new data from IMS Health, prescription pharmaceutical sales in Turkey soared 54% in 2005 - outstripping a 20% gain in Russia and a 15% rise in South Korea. Although the report did not release...
March 2006
Eczacibiasi Opens New Antibiotics Factory

Companies / Turkey Turkish drugmaker Eczacibasi Pharmaceuticals has recently opened a new US$4mn antibiotics facility, which will specialise in the production of cephalosporin. Eczacibasi Pharmaceuticals is planning to...
March 2006
Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2008 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS